By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellular Dynamics International (CDI) has reeled in $40.6 million in Series B private equity funding, the pluripotent stem cell developer said today.

The company plans to use the financing, which came from Sam Zell's Equity Group Investments and Sixth Floor Investors, to increase production capacity for its iCell Cardiomyocytes, which are human heart cells derived from induced pluripotent stem cells (iPSCs).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.

A National Science Foundation-funded project aims to give researchers access to a network many times faster than the Internet.

Bioethicists weigh the idea of charging patients to take part in clinical research, coming down against the approach.

Cornell's Christopher Mason and his colleagues correct their New York City microbiome study to emphasize "the difference between matching fragments of DNA from a species and a pathogen."